We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.8B
AUM Growth
-$421M
Cap. Flow
-$543M
Cap. Flow %
-11.33%
Top 10 Hldgs %
11.23%
Holding
2,126
New
460
Increased
575
Reduced
566
Closed
461

Sector Composition

Rank Sector Weight
1 Technology 16.81%
2 Consumer Discretionary 14.52%
3 Healthcare 12.46%
4 Industrials 12.28%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SID icon
1601
Companhia Siderúrgica Nacional
SID
$1.23B
$203K ﹤0.01%
+87,968
New +$193K
IGIB icon
1602
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$202K ﹤0.01%
3,800
-7,038
-65% -$375K
HA
1603
DELISTED
Hawaiian Holdings, Inc.
HA
$202K ﹤0.01%
+5,026
New +$199K
EEM icon
1604
iShares MSCI Emerging Markets ETF
EEM
$30B
$201K ﹤0.01%
4,647
-9,677
-68% -$418K
GM icon
1605
General Motors
GM
$76.8B
$201K ﹤0.01%
5,975
-341,113
-98% -$12.6M
ALGRW
1606
DELISTED
Allegro Merger Corp Warrant
ALGRW
$200K ﹤0.01%
+570,000
New +$191K
LTN.WS
1607
DELISTED
Union Acquisition Corp.
LTN.WS
$200K ﹤0.01%
570,000
LBY
1608
DELISTED
Libbey, Inc.
LBY
$195K ﹤0.01%
+22,145
New +$203K
MGNI icon
1609
Magnite
MGNI
$3.55B
$192K ﹤0.01%
+53,324
New +$188K
WRLSW
1610
DELISTED
Pensare Acquisition Corp. Warrant
WRLSW
$190K ﹤0.01%
345,000
MACK
1611
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$185K ﹤0.01%
45,001
-29,136
-39% -$123K
AGTC
1612
DELISTED
Applied Genetic Technologies Corporation
AGTC
$179K ﹤0.01%
+25,060
New +$110K
ALNA
1613
DELISTED
Allena Pharmaceuticals
ALNA
$178K ﹤0.01%
+16,593
New +$182K
LSAK icon
1614
Lesaka Technologies
LSAK
$420M
$172K ﹤0.01%
+21,774
New +$183K
UMC icon
1615
United Microelectronic
UMC
$46.9B
$169K ﹤0.01%
+66,066
New +$180K
AVNW icon
1616
Aviat Networks
AVNW
$273M
$168K ﹤0.01%
20,748
-22,504
-52% -$185K
BFIIW
1617
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$165K ﹤0.01%
411,759
OTIC
1618
DELISTED
Otonomy, Inc.
OTIC
$165K ﹤0.01%
+58,142
New +$187K
ARCT icon
1619
Arcturus Therapeutics
ARCT
$211M
$164K ﹤0.01%
18,700
-18,307
-49% -$152K
RMNI icon
1620
Rimini Street
RMNI
$471M
$164K ﹤0.01%
199,800
NEX
1621
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$164K ﹤0.01%
+13,210
New +$170K
SPRO icon
1622
Spero Therapeutics
SPRO
$73M
$158K ﹤0.01%
+13,716
New +$159K
AOSL icon
1623
Alpha and Omega Semiconductor
AOSL
$1.08B
$155K ﹤0.01%
13,368
-43,927
-77% -$603K
GORO icon
1624
Goldgroup Mining Inc.
GORO
$191M
$154K ﹤0.01%
30,002
-111,235
-79% -$643K
PHIIK
1625
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$151K ﹤0.01%
16,604
-24,159
-59% -$211K

Similar funds

Oxford Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Oxford Asset Management held 2,126 positions worth $4.8B, down 8.1% from $5.22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Oxford Asset Management withdrew a net $543M in Q3 2018, closing 461 positions and reducing 566 holdings. Its most notable exit was Cavium, Inc., an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in CA, Inc. worth $72.4M.

  • Oxford Asset Management's largest Q3 2018 buy was CA, Inc.: 1,645,180 shares worth $72.4M.
  • Oxford Asset Management added most to GTY Technology Holdings, Inc. Common Stock in Q3 2018, an estimated $26.6M increase.
  • Oxford Asset Management's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $85.7M.
  • Oxford Asset Management fully exited Cavium, Inc. in Q3 2018, selling an estimated $166M.
  • Oxford Asset Management's ten largest holdings make up 11% of its $4.8B portfolio in Q3 2018.
  • Oxford Asset Management opened 460 new positions and closed 461 in Q3 2018.
  • Oxford Asset Management's portfolio value fell 8.1% quarter-over-quarter to $4.8B.

Based on Oxford Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.